VBI Vaccines

VBI Vaccines is working on a locally developed COVID-19 vaccine as well as jabs that target diseases such as cancer and hepatitis B.
Massachusetts-based VBI Vaccines began clinical trials at the Ottawa Hospital this week on the first version of its product.
Variation Biotechnologies is working with the National Research Council to create a vaccine that would target the novel coronavirus as well as other deadly viruses.
An Ottawa-born pharmaceutical company is teaming up with the National Research Council in a bid to develop a vaccine that will target COVID-19 as well as two other deadly coronaviruses.